Generative AI in Healthcare Market
Get a free sample of this report
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Request Sectional Data
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The global generative AI in healthcare market was valued at USD 1.8 billion in 2023 and is expected to exhibit growth at a CAGR of 33.2% from 2024 to 2032. High market growth can be attributed to the advancements in deep learning and natural language processing (NLP), increasing demand for personalized treatment, growing investment in healthcare AI, and rising healthcare data volumes, among other contributing factors.
Moreover, the rapid advancement of deep learning models, including GPT and NLP tools, enables various healthcare applications. These include medical imaging analysis, automated reporting, and conversational AI for patient assistance. Such technological progress is driving the adoption of generative AI solutions in the healthcare sector.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Generative AI in Healthcare Market Size in 2023: | USD 1.8 Billion |
Forecast Period: | 2024 – 2032 |
Forecast Period 2023 - 2032 CAGR: | 33.2 |
2023 Value Projection: | USD 20.2 Billion |
Historical Data for: | 2021 – 2023 |
No of Pages: | 130 |
Tables, Charts & Figures: | 109 |
Segments Covered: | Application, End Use, and Region |
Growth Drivers: |
|
Pitfalls Challenges: |
|
Furthermore, governments, private organizations, and venture capitalists have been making significant investments in generative AI technologies to enhance healthcare efficiency. For instance, the U.S. government, through the National Institutes of Health (NIH), allocated USD 1.5 billion to AI research in healthcare between 2018 and 2022. This substantial funding has accelerated advancements in AI-driven drug discovery and medical diagnostics, fostering innovation and driving market expansion.
Generative AI in healthcare refers to the application of artificial intelligence (AI) techniques that involve the generation of new and original data. Also, in the healthcare sector, generative AI is used for tasks such as generating synthetic medical images, creating virtual patient data for training healthcare algorithms, simulating disease progression, and even designing novel molecules for drug discovery.
The market is experiencing several market trends that are shaping its growth and development. Factors such as advancements in artificial intelligence, increasing investment, and a focus on improving healthcare efficiency and outcomes, among other factors are boosting the industry growth.
Based on application, the market is classified into medical image analysis and diagnostics, drug discovery and development, patient assistance and monitoring, personalized treatment and other applications. The medical image analysis and diagnostics segment generated the highest revenue of USD 655.4 million in 2023.
Based on end use, the generative AI in healthcare market is segmented into healthcare providers, pharmaceutical and life sciences companies, and healthcare payors. The healthcare providers segment is further divided into hospitals and clinics, diagnostic centers, and other healthcare providers. The healthcare providers segment dominated the market in 2023 and is anticipated to reach USD 9.7 billion by the end of forecast period.
North America generative AI in healthcare market accounted for USD 758.7 million market revenue in 2023 and is anticipated to grow at a CAGR of 33.3% between 2024 to 2032 period.
Germany generative AI in healthcare market is projected to grow remarkably in the coming years.
China holds a dominant position in the Asia Pacific generative AI in healthcare market.
The market features a dynamic competitive landscape driven by major technology firms, healthcare-focused AI startups, and partnerships between industry leaders. Companies like Google LLC, NVIDIA Corporation, Microsoft, and IBM Corporation leverage their advanced AI capabilities to create innovative solutions for medical imaging, diagnostics, and patient engagement. Meanwhile, specialized players such as Abridge, PathAI, and Insilico Medicine offer niche generative AI tools tailored to healthcare applications like clinical documentation, pathology, and drug discovery. Collaboration between tech giants and healthcare providers further accelerates market growth, fostering innovation and increasing accessibility to AI-powered healthcare solutions.
Prominent players operating in the generative AI in healthcare industry include:
Market, By Application
Market, By End Use
The above information is provided for the following regions and countries:
The North America generative AI in healthcare market recorded USD 758.7 million in revenue in 2023 and is anticipated to grow at a CAGR of 33.3% between 2024 and 2032, supported by its advanced healthcare infrastructure.
North America, particularly the U.S. and Canada, leads due to its cutting-edge medical facilities, research institutions, and a robust network of hospitals and clinics adopting generative AI technologies to enhance patient care and optimize resource management.
Key players in the industry include Abridge AI, DiagnaMed Holdings, ELEKS, Google LLC (Alphabet), Insilico Medicine, International Business Machines, Microsoft, NVIDIA, Oracle, Persistent Systems, and Syntegra.
The global generative AI in healthcare industry was valued at USD 1.8 billion in 2023 and is expected to grow at a CAGR of 33.2% from 2024 to 2032, driven by advancements in deep learning and natural language processing (NLP).
The medical image analysis and diagnostics segment generated USD 655.4 million in revenue in 2023, fueled by the increasing global prevalence of chronic diseases.